Sulfonamides
High-yield Verified · Oct 2026Prototype: trimethoprim-sulfamethoxazole (Bactrim)
Sulfonamides are a class of medications used for urinary tract infections.
Trimethoprim-sulfamethoxazole and relatives — they starve bacteria of folate. A classic sulfa allergen.
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 Starving bacteria of folate
Bacteria make their own folate (folic acid) to build DNA — a pathway human cells lack, since we must get folate from the diet. Sulfonamides exploit this: sulfamethoxazole blocks an early enzyme (dihydropteroate synthase) in the bacterial folate pathway, and its partner trimethoprim blocks a later one (dihydrofolate reductase). Hitting two sequential steps produces a powerful synergistic effect that can be bactericidal in some settings (e.g., the urinary tract) — which is why the two are combined as TMP-SMX (Bactrim).
Because human cells get folate from the diet and don’t use these enzymes the same way, the drug is relatively selective for bacteria. TMP-SMX is a workhorse for UTIs, MRSA skin infections, and Pneumocystis (PCP) prophylaxis/treatment.
02 The four things that go wrong
Four safety themes define sulfonamides. (1) Sulfa allergy: they are the classic "sulfa" drugs and can cause severe skin reactions — from rash to Stevens-Johnson syndrome / toxic epidermal necrolysis (SJS/TEN). (2) Crystalluria: the drug can precipitate in the urine and injure the kidney — so patients must push fluids. (3) Hyperkalemia: trimethoprim blocks a sodium channel in the kidney (amiloride-like), raising potassium — important with ACE-I/ARBs, potassium-sparing diuretics, or renal disease.
(4) The folate connection reaches human cells too at the margins: it can cause blood dyscrasias (megaloblastic anemia, leukopenia), and in a newborn the sulfa displaces bilirubin from albumin, causing kernicterus — which is why it’s avoided in late pregnancy and infants under 2 months. It also potentiates warfarin and methotrexate.
Drug names
Indications
- Urinary tract infections, including pyelonephritis and prostatitis
- MRSA / community-acquired skin & soft-tissue infections
- Pneumocystis jirovecii pneumonia (PCP) treatment & prophylaxis; some GI infections
Mechanism of action
Sequential blockade of bacterial folate synthesis: sulfamethoxazole inhibits dihydropteroate synthase (a PABA analog) and trimethoprim inhibits dihydrofolate reductase — synergistic; bactericidal in some settings (each drug alone is bacteriostatic). Bacteria must synthesize folate, giving selectivity over human cells.
Therapeutic effects — what you'll see working
Success is clearing the UTI, skin, or PCP infection. The nursing focus is screening for sulfa allergy, pushing fluids, and watching potassium and blood counts.
- Synergistic bacterial kill
- Blocking two sequential folate steps is more effective than either alone — the basis for the fixed TMP-SMX combination.
- Broad practical coverage
- Reliable for many UTIs and community MRSA, and the standard for Pneumocystis prophylaxis in immunocompromised patients.
Adverse effects
The adverse effects are the four safety themes — hypersensitivity, crystalluria, hyperkalemia, and hematologic/neonatal folate effects — plus less common but serious hyponatremia, hypoglycemia, and HLH.
Interactions
Contraindications
The contraindications are prior sulfa reactions, the neonatal/pregnancy window, and the interactions/renal states that magnify harm. The label also bars use after drug-induced immune thrombocytopenia, with folate-deficiency megaloblastic anemia, marked liver damage, or unmonitored severe renal insufficiency, and with dofetilide.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Common questions
What are Sulfonamides used for?
How do Sulfonamides work?
What are the serious side effects of Sulfonamides?
Conditions treated
Trimethoprim-sulfamethoxazole with metronidazole — an alternative oral regimen.
"Trimethoprim-sulfamethoxazole is used for Pneumocystis jirovecii prophylaxis in T-cell defects and chronic granulomatous disease."
Culprit — trimethoprim-sulfamethoxazole. Bactrim: "should be discontinued at the first appearance of skin rash or any sign of a serious adverse reaction"; patients should "stop taking BACTRIM immediately" for rash, sore throat, fever, joint pain, cough, purpura or jaundice and contact their provider.
PCP prophylaxis — "most commonly Bactrim for PCP" in the first 3–6 months (StatPearls, kidney transplant).
TMP-SMX pairs sulfamethoxazole with trimethoprim in a sequential blockade of bacterial folate synthesis — together bactericidal — and is a first-line oral option for uncomplicated cystitis. The catch is empiric wisdom: review the local antibiogram first — regional resistance patterns decide whether it is usable before culture results exist. In pregnancy it is avoided in the third trimester (bilirubin displacement → fetal kernicterus risk) and in the first when alternatives exist (malformation risk).
See also
The original β-lactams — bactericidal cell-wall inhibitors. The defining nursing job is screening for and recognizing allergy, from rash to anaphylaxis.
β-lactam cousins of penicillin, organized by generation — each generation trades some gram-positive reach for broader gram-negative coverage.
Powerful, broad-spectrum DNA-synthesis blockers — but a boxed warning for disabling tendon, nerve, and CNS effects means they’re reserved when alternatives exist.
Suppress viral replication rather than kill viruses outright. The nursing essentials: hydrate with acyclovir, start early (flu within 48 h), and remember most antivirals suppress — they don’t cure.
Powerful IV drugs for serious Gram-negative infection — but nephrotoxic and ototoxic. Levels matter.
Broad, generally safe protein-synthesis inhibitors — a penicillin-allergy alternative. Watch QT and CYP3A4.
Sources
- Trimethoprim-Sulfamethoxazole — folate mechanism, SJS, hyperkalemia, adverse effects — StatPearls (NCBI)
- BACTRIM (sulfamethoxazole/trimethoprim) — contraindications, SCARs, HLH, hyperkalemia, hyponatremia, crystalluria, drug interactions (FDA label) — FDA / DailyMed
- Hypoaldosteronism — trimethoprim blocks epithelial sodium channels — StatPearls (NCBI)
- Folic Acid — humans cannot synthesize folate — StatPearls (NCBI)
- Sulfa drugs and bacterial de novo folate synthesis (PLoS Pathog 2016) — PMC (CC BY)
- Opportunistic Infections in Adults with HIV — Pneumocystis prophylaxis — NIH (clinicalinfo.hiv.gov)
- The use of stems in the selection of International Nonproprietary Names (sulfa-) — World Health Organization
- Pregnancy Medications — TMP-SMX near term (kernicterus) — StatPearls (NCBI)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.